Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
240 participants
INTERVENTIONAL
2011-07-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to show that an optimization of the caring of non controlled hypertended patients following a CVA (including a preliminary Tensional auto-measure (TAM) at the follow-up visit, an education of the patient with a decision support tree for the generalist and/or a visit in the multidisciplinary AHT department), allow to obtain a better tensional control copared to the usual caring.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All the hypertended patients able to realise a course of tensional automeasures will be invited to realise a course of tensional auto-measures during three days preceding the visit in the neurology department.
The tensional measures will be performed according the methodology recommended by HAS.
This strategy of caring is conform to the HAS and ESH recommendations regarding the follow up of the hypertended patients.
The hospitalised patients in neurology for CVA are in all cases convocated to the follow up visit three months after the hospitalisation. The patients will be trained in the use of the TAM by the nurse of the neurology depratment before his dropout from the neurology department at the end of hospitalisation.
The systematic use of TAM will allow to identify patients presenting a AHT "white blouse", but too patients presenting masked AHT.
The visit in the neurology department will be performed by the investigators of the neurology department. At the end of this visit, two groups of patients will be identified : patients with a controlled AHT (NI), and patients with a masked or non controlled AHT (MASC + NC).
Patients presenting a controlled AHT or a "white blouse" AHT (NI) will not be randomised. But it will be proposed to them to sign a consent to acquire their agreement to realise a exploitation of their data. This will allow to caracterise better this population of patients.
Patients presenting a masked or non controlled AHT will be invited to participate to the study after signing a consent.
The collection of the consent will be done by the investigators of the neurology department.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Group of patients presenting a non controlled AHT or a masked AHT, benefiting from an optimised caring at visit 0.
Auto-measure of the tension by an autotensiometer
All hypertended patients able to realise a serie of tensional auto-measures will be invited to realise a serie of tensional auto-measures theree days before the consultation in the neurology department.
The auto-measures will be performed according the methodology recommended by HAS.
Control group
Patients presenting a non controlled AHT(persistent AHT, AHT necessiting an adaptation of the treatment by the generalist) with information of the generalist on the necessity of obtaining the tensional control according the HAS recommendations
Auto-measure of the tension by an autotensiometer
All hypertended patients able to realise a serie of tensional auto-measures will be invited to realise a serie of tensional auto-measures theree days before the consultation in the neurology department.
The auto-measures will be performed according the methodology recommended by HAS.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Auto-measure of the tension by an autotensiometer
All hypertended patients able to realise a serie of tensional auto-measures will be invited to realise a serie of tensional auto-measures theree days before the consultation in the neurology department.
The auto-measures will be performed according the methodology recommended by HAS.
Auto-measure of the tension by an autotensiometer
All hypertended patients able to realise a serie of tensional auto-measures will be invited to realise a serie of tensional auto-measures theree days before the consultation in the neurology department.
The auto-measures will be performed according the methodology recommended by HAS.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ischemic or haemorragic CVA or TIA necessiting an hospitalisation or a consultation in the neurolgy department, from more than 2 months.
* Pression ≥140/90 ou 130/80 (diabetic) during the post CVA consultation and a mean TAM ≥135/85 ou 125/75 (diabetic) = non controlled AHT OR Pression \< 140/90 ou 130/80 (diabetic) during the post CVA consultation and a mean TAM ≥ 135/85 ou 125/75 (diabetic) = masked AHT
* Patient agreed to participate to the study and having signed the informed consent from
Exclusion Criteria
* Persistance of a carotids bilateral stenosis from more than 70%
* Severe Renal Insufficiency (Creatinin Clearance estimated by the formula MDRD \< 30 ml/mn)
* CVA with major sequelae which according the judgement of the investigator will not allow to realise TAM :
* Major Cognitive Troubles
* Severe motor Troubles
* Severe concomitant Pathology
* Patient not speaking and not understanding french.
* Contre-indications to the realisation of TAM :
* Cardiac Arythmy
* Obese Patients for which the circumference of the arm is \> 33 cm
* Patient refusing to go to the 3 months after hospitalisation follow up consultation.
* Patient with no identified generalist
* Patient refusing to sign the informed consent form.
* Absence of affiliation to a Social system.
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nancy
Nancy, France, France
CH Bar Le Duc
Bar-le-Duc, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jean-Marc BOIVIN, MD,
Role: primary
Sanae BOUALI, PhD
Role: backup
Sébastien RICHARD, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hippocrate
Identifier Type: -
Identifier Source: org_study_id